Product Information
CARBIDOPA-LEVODOPA 25-250 TAB is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.1149 per EA under NDC 62756098501. Its NADAC has been published 191 times since Jun 29, 2022.
FDA first approved this application on Oct 28, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25; 250 mg/1; mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
62756098501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
CARBIDOPA; LEVODOPAApproval Type
Generic (ANDA)
FDA Application
ANDA078536FDA Approved
10/28/2008
TE Code
AB
On Market Since
8/12/2021
Pharmacological Classes
Price Statistics
The NADAC for CARBIDOPA-LEVODOPA 25-250 TAB has been published 191 times since Jun 29, 2022, and over the history we have for it it has declined 23.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1149 per EA |
|---|---|
| All-time high | $0.1512 (Oct 12, 2022) |
| All-time low | $0.0731 (Apr 17, 2024) |
| 52-week high | $0.1334 |
| 52-week low | $0.1149 |
| Median price | $0.1375 |
| Average price | $0.1317 |
| Largest weekly change | +71.8% (Jun 19, 2024) |
| Weeks tracked | 191 |
| Tracking since | Jun 29, 2022 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-13.9%
3Y
-16.4%
5Y
N/A
All
-23.1%
Last surveyed Feb 18, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CARBIDOPA-LEVODOPA 25-250 TAB?
The current National Average Drug Acquisition Cost (NADAC) for CARBIDOPA-LEVODOPA 25-250 TAB, manufactured by Sun Pharmaceutical Industries Inc., is $0.1149 per EA (NDC 62756098501), effective Feb 18, 2026.
How has the price of CARBIDOPA-LEVODOPA 25-250 TAB changed over time?
Over the history we have for it, the NADAC for CARBIDOPA-LEVODOPA 25-250 TAB has declined 23.1%. It has been tracked across 191 weekly CMS publications since Jun 29, 2022.
What are the highest and lowest recorded NADAC prices for CARBIDOPA-LEVODOPA 25-250 TAB?
Since Jun 29, 2022, the NADAC for CARBIDOPA-LEVODOPA 25-250 TAB has ranged from a low of $0.0731 (Apr 17, 2024) to a high of $0.1512 (Oct 12, 2022), with a median of $0.1375 per EA.
Are there cheaper alternatives to CARBIDOPA-LEVODOPA 25-250 TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CARBIDOPA-LEVODOPA 25-250 TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures CARBIDOPA-LEVODOPA 25-250 TAB?
CARBIDOPA-LEVODOPA 25-250 TAB (NDC 62756098501) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.